14.11.2012 Views

Mondobiotech Holding AG Company presentation

Mondobiotech Holding AG Company presentation

Mondobiotech Holding AG Company presentation

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Management<br />

Ruggero<br />

Gramatica<br />

CEO<br />

Dorian<br />

Bevec<br />

CSO<br />

Paolo<br />

Barbieri<br />

CFO<br />

Maria Teresa<br />

D’Antonangelo<br />

Bühlmann<br />

Corporate Affairs<br />

Business Support<br />

Ruggero has extensive experience in startups having successfully delivered growth and expansion<br />

to 6 companies in the technology arena worldwide. He brings strategic leadership and operational<br />

expertise. He has masterminded the bio-mathematical model which supports the company’s research<br />

approach and he remains academically involved in research activity in the field of Applied Mathematics<br />

with Kings College, London. Ruggero attended ‘Politecnico di Milano’ and obtained a BS-Eng and<br />

an MSc in Electrical Engineering and holds an MBA from the University of Chicago.<br />

Dr. Habil. Dorian Bevec is <strong>Mondobiotech</strong>’s Chief Scientific Officer and a co-founder of <strong>Mondobiotech</strong>.<br />

Dorian Bevec holds a Ph.D. (Dr. rer. nat.) from the Ludwig-Maximilians University of Munich and a<br />

habilitation (Venia Docendi) from the University of Vienna. Prior to that, Dorian had worked as Head of<br />

Molecular Biology and project team leader at the Sandoz Research Institute in Vienna for ten years and<br />

previously at Axxima <strong>AG</strong> in Martinsried.<br />

Paolo brings over 25 years of senior management, financial and capital market experience. Prior to joining<br />

mondoBIOTECH, he was Deputy CEO and Chief Investment Officer at Pioneer Alternative Investments, he<br />

has successfully founded and managed Akros HFR Alternative Investments and has been Managing<br />

Director and Head of Equity Capital Markets at Banca Akros.<br />

Maria Teresa is an attorney-at-law and is admitted to bar since 2003. She gained an in-depth knowledge<br />

and experience in international commercial law and intellectual property law, with a specialization in<br />

patents and copyright. Before joining <strong>Mondobiotech</strong> in 2005, she worked as associate in the law-firm<br />

Freshfield Bruckhaus Deringer in Milan and Paris and from 2001 until 2005 as senior associate in the law<br />

firm Avvocati Associati in Milan.<br />

4

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!